Department of Defense

Latest Headlines

Latest Headlines

Abbott gets $20M from DOD to develop portable concussion test

Abbott Laboratories and the United States Department of Defense are collaborating to develop a test that can be used to assess potential concussions quickly in the field. Abbott's handheld diagnostic i-Stat System is already in use by the military; the test will be developed for use on it.

NeuroPace stimulator to be deployed in $40M DOD brain research initiative

The $40 million Department of Defense research program into restoring memory will use NeuroPace's implantable neurostimulator, a move that the company said could help it expand the product's indications beyond epilepsy.

DOD awards $40M for wireless implant for memory loss due to brain injury

Soon, there will be a device to cure some forgetfulness if the Department of Defense's four-year grant of up to $40 million succeeds in fostering implants and electronic interfaces that diagnose and treat memory loss due to traumatic brain injury.

Defense Department funds nanotech organ injury detection

Implantable drug delivery startup Pharmaco-Kinesis has persuaded the U.S. Department of Defense to fund another potential use for its technology.

DOD selects Bavarian Nordic to develop vaccine against biological threats

The Department of Defense has selected Denmark's Bavarian Nordic to develop a vaccine against two potential biological pathogens deemed to be threats to national security.

DoD ponies up $15M to develop Terumo's blood-cleaning tech

Terumo BCT, the blood-focused division of the Japanese med tech giant, has signed a deal with the U.S. Department of Defense to share costs in the development of a device that can treat donated blood used in emergency transfusions.

Combat Medical Systems gains $86M govt. contract

Founded just 5 years ago, Combat Medical Systems nailed down an $86 million U.S. Department of Defense contract to provide a slew of medical equipment and devices for military and federal agencies over the next 5 years.

Sarepta reports promising preclinical results for antibioterrorism drug

Sarepta Therapeutics is getting closer to developing a therapy to treat a rare animal-borne disease considered a bioterrorism threat by the Centers for Disease Control and Prevention.

General Dynamics lands a $42M DoD drug development contract

The big defense contractor General Dynamics is hiring a team to help it execute on a $41.8 million contract to develop new drugs, devices and vaccines for the military.

Video game players take on deadly sepsis for U.S. military

A unit of the U.S. Department of Defense has challenged the Foldit video gamers to craft proteins in a virtual online setting that bind to pathogens in the blood, to bolster research of sepsis treatments.